Global Market for LDT Evolving, Shifting, and Growing (6.3% CAGR)
June 29, 2017 05:00 ET
|
BCC Research
Wellesley, Mass., June 29, 2017 (GLOBE NEWSWIRE) -- The laboratory-developed test (LDT) market is evolving due to a variety of technological, financial and regulatory factors that will shift the...
Laboratory Heads from World-Renowned Academic Medical Centers Urge OMB Not to Release FDA Guidance on the Regulation of Laboratory-Developed Tests (LDTs)
July 16, 2014 14:45 ET
|
ARUP Laboratories
SALT LAKE CITY, July 16, 2014 (GLOBE NEWSWIRE) -- Leading diagnostic innovators and laboratory directors from the nation's most respected nonprofit, academic medical centers have issued a letter...
Atossa Genetics to Conduct Free Webinar: How to Invest Ahead of Breast Cancer Awareness Month
September 23, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Sep 23, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, today announced that Dr. Steven C. Quay, Chairman, President & CEO, will...
Peter J. Carbonaro Joins Atossa Genetics as Senior Vice President of Operations
June 05, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - Jun 5, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Peter J. Carbonaro has joined the Company as Senior Vice...
Atossa Genetics to Present at the Sachs Associates Cancer Bio Partnering Forum and Participate on the Cancer Tech Panel
May 14, 2013 08:30 ET
|
Atossa Genetics, Inc.
SEATTLE, WA--(Marketwired - May 14, 2013) - Atossa Genetics, Inc. (NASDAQ: ATOS), The Breast Health Company™, announced today that Dr. Steven Quay, Chairman, CEO & President, will speak...